首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study
【24h】

Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study

机译:腹膜内万年霉素加上口服莫西沙星或腹膜内的头孢他啶治疗腹膜透析相关的腹膜炎:随机对照试验研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Intraperitoneal administration of antibiotics is recommended as a first treatment for managing peritoneal dialysis (PD)-related peritonitis. However, the efficacy of oral administration of quinolones has not been well studied.
机译:背景:建议腹膜内施用抗生素作为用于管理腹膜透析(PD)相关腹膜炎的第一次治疗方法。 然而,口服喹诺酮类药物的疗效尚未得到很好的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号